Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Compare regional ETFs by cash flow to find the strongest income generator. A quick guide to optimize regional yield strategies.
26,816 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A landmark 1964 box set known as The Folk Box is being revisited as a case study on how culture becomes cash. Its leg...
As AI reshapes business, three stock ideas stand out for potential multi-year gains. This guide breaks down why, how ...
PepsiCo stock faces a fresh price prediction this popular blue-chip dividend stock, with an upside case built on inte...
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
When margaret qualley jack antonoff separate, more than headlines are at stake. This guide breaks down how to shield ...
Analysts issued fresh price targets on nine stocks, signaling divergent views as U.S. markets contend with rate uncer...
As an investor, timing updates can boost or trim returns. This guide breaks down whether should taiwan semiconductor ...
Unity Software’s latest guidance sparked a sharp rally, underscoring how Vector AI could redefine monetization in int...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
Hut 8 is pivoting to AI data center infrastructure, prompting a Canaccord upgrade that nearly doubles the firm’s pric...
If you’re wondering should apple stock before June 8, you’re not alone. This guide breaks down the catalysts, risks, ...